BW Communities

author-image

C H Unnikrishnan

Author

Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals. 

Latest Articles By C H Unnikrishnan

BW Real 500: At An Alltime High

The corporation, with its asset base touching Rs 93,241 crore, and its sales and profit at Rs 1,88,651 crore and Rs 8,463 crore respectively, is in the top 10 of BW Real 500 again

Read More
Family Businesses: Winds Of Change

Family run businesses still dominate corporate India, but many are now opting to let professionals run the show

Read More
Healthcare: Personal Healing

Different bodies have different needs — from nutrients to medicines. That’s where the future of healthcare is

Read More
Sun Pharma Buys Novartis’ Anti-cancer Brand Odomzo For $175 Million

Reason for selling this new anti-cancer drug by Novartis, which consolidated its global oncology business by acquiring the entire cancer drug portfolio of GlaxoSmithKline (GSK) in a $16 billion global deal in March 2015, is not disclosed

Read More
PSUs: Power Of A Collective

The Indian government by virtue of its majority ownership in public sector companies, including banks and oil marketers, has become richer by Rs 1,44,637 crore in 2016 compared to the previous year

Read More
Refuse Of Tax Evaders?

Curbs on exchange of old currency and the ‘black money haven’ tag have stalled the cooperative banking sector

Read More
Tata Sons: A Bitter Pill

The Tata-Mistry battle has now percolated down to the boardrooms of group companies, portending mayhem

Read More
‘India Is A Potential Market For Alcohol’

Diageo, the world’s largest spirit and alcoholic beverages company, wants to transform the practices in Indian market

Read More
Sun Pharma Buys Russian Drug Maker JSC Biosintez

JSC is currently engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region mainly focusing on the hospital segment had annual revenues of approximately $ 52 million in 2015

Read More
Vymo Raises Series A Funding From Sequoia

Predictive sales analytics start-up Vymo said on Tuesday (22 Oct.) that it has raised $5 million Series A fund from Sequoia India

Read More

Subscribe to our newsletter to get updates on our latest news